Effect of drug type on the degradation rate of PLGA matrices

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 64, Issue 3, 2006, Pages 287-293

  Siegel, Steven J ^a   Kahn, Jonathan B ^a   Metzger, Kayla ^a   Winey, Karen I ^a   Werner, Kathryn ^b   Dan, Nily ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Drexel University   (United States)

Author keywords

Controlled release; Diffusion reaction; Kinetics; PLGA; Solubility

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTERONE; DRUG CARRIER; HALOPERIDOL; HYDROCHLOROTHIAZIDE; IBUPROFEN; POLYGLACTIN; POLYMER; TIOTIXENE;

ARTICLE; BIODEGRADABILITY; DRUG DEGRADATION; DRUG DESIGN; DRUG RELEASE;

ANTI-INFLAMMATORY AGENTS; ANTIPSYCHOTIC AGENTS; ASPIRIN; BIOCOMPATIBLE MATERIALS; CORTICOSTERONE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; HALOPERIDOL; HYDROCHLOROTHIAZIDE; HYDROLYSIS; IBUPROFEN; KINETICS; LACTIC ACID; MODELS, CHEMICAL; POLYGLYCOLIC ACID; POLYMERS; SOLUBILITY; THIOTHIXENE; TIME FACTORS;

EID: 33750048727     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.06.009     Document Type: Article

References (33)

1. Adams C.E., Fenton M.K., Quraishi S., and David A.S. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br. J. Psychiatry 179 (2001) 290-299
2. Ayuso-Gutierrez J.L., and del Rio Vega J.M. Factors influencing relapse in the long-term course of schizophrenia. Schizophr. Res. 28 (1997) 199-206
3. Boccuzzi S.J., Wogen J., Fox J., Sung J.C.Y., Shah A.B., and Kim J. Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diab. Care 24 (2001) 1411-1415
4. Chui M.A., Deer M., Bennett S.J., Tu W.Z., Oury S., Brater C., and Murray M.D. Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy 23 (2003) 326-332
5. Corriss D.J., Smith T.E., Hull J.W., Lim R.W., Pratt S.I., and Romanelli S. Interactive risk factors for treatment adherence in a chronic psychotic disorders population. Psychiatry Res. 89 (1999) 269-274
6. Curtis H. Biology. In: Anderson S. (Ed) (1983), Worth Publishers, New York
7. Dash A.K., and Cudworth II G.C. Therapeutic applications of implantable drug delivery systems. J. Pharmacol. Toxicol. Methods 40 (1998) 1-12
8. Fischel-Ghodsian F., and Newton J.M. Analysis of drug release kinetics from degradable polymeric devices. J. Drug. Target 1 (1993) 51-57
9. Foster R.H., and Goa K.L. Risperidone. A pharmacoeconomic review of its use in schizophrenia. Pharmacoeconomics 14 (1998) 97-133
10. Freiberg S., and Zhu X. Polymer microspheres for controlled drug release. Int. J. Pharmaceut. 282 (2004) 1-18
11. Holy C.E., Dang S.M., Davies J.E., and Shoichet M.S. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. Biomaterials 20 (1991) 1177-1185
12. Lu L., Peter S.J., Lyman M.D., Lai H.L., Leite S.M., Tamada J.A., Uyama S., Vacanti J.P., Langer R., and Mikos A.G. In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams. Biomaterials 21 (2001) 1837-1845
13. Narasimhan B., and Peppas N.A. Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier. J. Pharma. Sci. 86 (1997) 297-304
14. Miller-Chou B.A., and Koenig J.L. A review of polymer dissolution. Progress Pol. Sci. 28 (2003) 1223-1270
15. Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Pol. Int. 54 (2005) 36-46
16. Larobina D., Mensitieri G., Kipper M.J., and Narasimhan B. Mechanistic understanding of degradation in bioerodible polymers for drug delivery. AICHE J. 48 (2002) 2960-2970
17. Frank A., Rath S.K., and Venkatraman S.S. Controlled release from bioerodible polymers: effect of drug type and polymer composition. J. Control. Release 102 (2005) 333-344
18. Kiortosis S., Kachrimanis K., Broussali Th., and Malamataris S. Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Europ. J. Pharma. Biopharma. 59 (2005) 73-83
19. Li S., Girod-Holland S., and Vert M. Hydrolytic degradation of poly(d,l-lactic acid) in the presence of caffeine base. J. Control. Release 40 (1996) 41-53
20. Sung K.C., Han R.-Y., Hu O.Y.P., and Hsu L.-R. Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophillicity and polymer composition. Int. J. Pharm. 172 (1998) 17-25
21. Anderson J.M., and Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Delivery Rev. 28 (1997) 5-24
22. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Delivery Rev. 55 (2003) 329-347
23. Gander B., Meinel L., Walter E., and Merkle H.P. Polymers as a platform for drug delivery: Reviewing our current portfolio on poly(lactide-co-glycolide) (PLGA) microspheres. CHIMIA 55 (2001) 212-217
24. Grayson A.C.R., Cima M.J., and Langer R. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance. Biomaterials 26 (2005) 2137-2145
25. Crank J. The Mathematics of Diffusion. second ed. (1975), Oxford University Press
26. Crank J., and Park G.S. Diffusion in Polymers (1968), Academic Press, New York
27. Siepmann J., and Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv. Drug Delivery Rev. 48 (2001) 229-247
28. Thombre A.G., and Himmelstein K.J. A simultaneous transport-reaction model for controlled drug delivery from catalyzed bioerodible polymer matrices. AIChE J. 5 (2004) 759-766
29. Faisant N., Siepmann J., and Benoit J.P. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur. J. Pharmaceut. Sci. 15 (2002) 355-366
30. Lyu S., Sparer R., and Untereker D. Analytical solutions to mathematical models of the surface and bulk erosion of solid polymers. J. Pol. Sci. B: Pol. Phys. 43 (2005) 383-397
31. Siepmann J., Elkharraz K., Siepmann F., and Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. Biomacromolecules 6 (2006) 2312-2319
32. Zheng H.M., Jacob K.I., and Tikare V. Numerical simulations of crystal growth in a transdermal drug delivery system. J. Cryst. Growth 262 (2004) 602-611
33. Variankaval N.E., Jacob K.I., and Dinh S.M. Characterization of crystal forms of beta-estradiol-thermal analysis, Raman microscopy, X-ray analysis and solid-state NMR. J. Cryst. Growth 217 (2000) 320-331